VLTTF yields 1053.19% · JNJ yields 2.13%● Live data
📍 VLTTF pulled ahead of the other in Year 1
Combined, VLTTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VLTTF + JNJ for your $10,000?
Volatus Aerospace Corp. provides integrated drone solutions for commercial and defense markets in Canada, the United States, Latin America, the United Kingdom, and rest of Europe. The company offers drone services, including infrastructure inspection, mapping, survey, and imaging; and drone training and consulting services comprising pilot certification, flight skills, equipment training, beyond-visual-line-of-sight readiness, as well as OEM equipment testing and certification, operational manuals, SOPs, safety systems, SORA, waivers, and SFOCs. It also provides sensors and other ancillary components and equipment; unmanned systems equipment sales and servicing; GIS solutions; and data processing and management, maintenance, and repair services for various industries, as well as researches and develops, manufactures, tests, and commercializes various technologies. In addition, the company offers aircraft management, charter, and cargo services; and public safety and defense equipment and solutions. Volatus Aerospace Corp. is based in Oro-Medonte, Canada.
Full VLTTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.